News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PrimeraDx Featured in the Goldman, Sachs & Co. Healthcare Research Team's GS Emerging Healthcare Series



5/10/2013 9:35:16 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MANSFIELD, Mass., May 9, 2013 /PRNewswire/ -- PrimeraDx, Inc., a molecular diagnostics company, will be highlighted in a conference call with the Goldman Sachs Healthcare Research Team as part of the GS Emerging Healthcare Series on May 13, 2013 at 11 am. Matthew McManus, MD, Ph.D., President and CEO of PrimeraDx will provide an overview of the Company's innovative technology and its two-pronged approach to the market: offering an "open platform" system to reference labs, academic medical centers and large hospital systems and also partnering with pharmaceutical companies to develop cutting-edge companion diagnostic products. Isaac Ro, Goldman Sachs Life Science Tools & Diagnostics Analyst will host the call.

Dial in information: 877-208-2954 or 973-528-0056
Conference Entry Code: 938134
Webcast: http://www.visualwebcaster.com/event.asp?id=94044

Replay information
Access #: 800.332.6854 OR 973.528.0005
Conference Entry Code: 938134
Dates: 5/13 5/27 (2 weeks)

About PrimeraDx
PrimeraDx is a molecular diagnostics company marketing an innovative clinical platform which combines PCR with capillary electrophoresis for multiplexed, information-rich molecular diagnostics used in Oncology, Infectious Disease, and Genetic Testing. The result of combining these two well-known technologies into a bench-top instrument is the ability to deliver highly multiplexed, multi-modal, and quantitative answers to the clinic. Users can easily design very complex assays that simultaneously test for disparate target types, like SNPs, expression biomarkers, microRNAs and fusion genes. PrimeraDx's technology represents the next generation of quantitative, multiplex PCR. The Company is backed by a strong group of experienced venture-capital investors, including Abingworth, InterWest Partners, CHL Medical Partners, and Malaysian Technology Development Corporation. The Company's website is: www.primeradx.com.

CONTACT: Ted Myles, CFO, (508) 618-2300

SOURCE PrimeraDx, Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES